Serán Bioscience
Serán Bioscience raises $200M Venture at $900M valuation
Serán Bioscience: Venture Funding Round
Serán Bioscience has successfully raised $200M in Venture funding, reaching a valuation of $900M.
Company Overview
Provides development and manufacturing services to pharmaceutical and biotech companies
Funding Details
The Venture round was led by Foresite Capital, with participation from OrbiMed.
Company Information
- Headquarters: Bend, OR
- Founded: 2017
- Employees: 300+
- Category: Biotech
Investment
Serán Bioscience plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Foresite Capital: Verified investor in Venture
- OrbiMed: Verified investor in Venture
Company Info
Investors (2)
Share
Related Reports
AusperBio Raises $73M Series B
Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free